Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease

Neuroscience

• Synaptic Plasticity 100%
• Alzheimer's Disease 100%
• Glucagon-Like Peptide-1 100%
• Liraglutide 55%
• Exendin 9 22%
• Insulin Signaling 22%
• Hippocampus 11%
• Cognitive Process 11%
• Neurodegenerative Process 11%
• Incretin 11%
• Receptor Antagonist 11%
• Glucagon-Like Peptide 1 Receptor 11%
• Carboxamide 11%
• Synaptic Transmission 11%

Biochemistry, Genetics and Molecular Biology

• Nerve Cell Plasticity 100%
• Glucagon-Like Peptide-1 100%
• Liraglutide 55%
• Insulin Signaling 22%
• Receptor Antagonist 11%
• Insulin Release 11%
• Enzyme 11%
• Glycemic Control 11%
• Glucagon-Like Peptide 1 Receptor 11%
• Incretin 11%
• Synaptic Transmission 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucagon-Like Peptide-1 100%
• Alzheimer's Disease 100%
• Liraglutide 55%
• Non Insulin Dependent Diabetes Mellitus 22%
• Glucagon-Like Peptide 1 Receptor 11%
• Receptor Antagonist 11%
• Incretin 11%
• Carboxamide 11%